Spinal muscular atrophy type II

[MIM*253550] a form intermediate in severity between the infantile form (SMA type I) and the juvenile form (SMA type III); characterized by proximal muscle weakness with onset usually between 3 and 15 months of age and survival until adolescence; autosomal recessive inheritance, caused by mutation in the SMN1 gene on 5q.

As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
© Copyright 2025 Chemwatch
Chemwatch
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.